PRESS RELEASE  Affluent Medical Announces Participation in Upcoming Scientific Events Aix-en-Provence, October 8, 2024 – 5:45 p.m. CEST – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME – "Affluent"), a French clinical-stage medical technology company specializing in the international development and industrialization of implantable innovativ [ … ]

PRESS RELEASE  H1 2024 RESULTS Major advances in all three programs Several strategic agreements signed with the world medtech leader in cardiology Extension of financial runway to July 2025  Several agreements signed in July 2024 with Edwards Lifesciences for an initial amount of €15m and an option to acquire the rights for KaliosTM Positiv [ … ]

PRESS RELEASE  Affluent Medical to attend German Fall Conference in Frankfurt in September 2024   Aix-en-Provence, August 22, 2024 – 7:30 am – Affluent Medical (ISIN: FR0013333077 – Ticker: AFME - “Affluent”), a French clinical-stage medical technology company specializing in the international development and industrialization of innovative medic [ … ]

PRESS RELEASE  Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of a category of beneficiaries Aix-en-Provence, July 15, 2024 – 7:45 a.m. - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a Fren [ … ]

Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment   Aix-en-Provence, July 12, 2024 - 7:45 am - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME - “Affluent”), a French clinical-stage medical technology company specializing in the international development and industrialization of innovative medical dev [ … ]

PRESS RELEASE Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter Second successful implantation of the innovative Artus medical device in Krakow, Poland Successful activation of the Artus device in the first two patients six weeks after surgery Artus, an  [ … ]

PRESS RELEASE Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter Second successful implantation of the innovative Artus medical device in Krakow, Poland Successful activation of the Artus device in the first two patients six weeks after surgery Artus, an  [ … ]